Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.560EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.610EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.10 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.286EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.369EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.73 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.60 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.124.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GS.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-9921.83South Korea
GJ.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XYEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.80 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.8 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
AY.128 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.220EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.257EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.323EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.105 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.398EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.94 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used